- Home
- CMPX vs ACDC Comparison
CMPX vs ACDC Comparison
Compare CMPX & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ACDC
- Stock Information
- Founded
- CMPX 2014
- ACDC 2014
- Country
- CMPX United States
- ACDC United States
- Employees
- CMPX N/A
- ACDC N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ACDC Oilfield Services/Equipment
- Sector
- CMPX Health Care
- ACDC Energy
- Exchange
- CMPX Nasdaq
- ACDC Nasdaq
- Market Cap
- CMPX 730.9M
- ACDC 712.6M
- IPO Year
- CMPX N/A
- ACDC 2022
- Fundamental
- Price
- CMPX $4.03
- ACDC $4.30
- Analyst Decision
- CMPX Strong Buy
- ACDC Sell
- Analyst Count
- CMPX 7
- ACDC 4
- Target Price
- CMPX $14.71
- ACDC $6.13
- AVG Volume (30 Days)
- CMPX 1.9M
- ACDC 1.3M
- Earning Date
- CMPX 11-11-2025
- ACDC 11-05-2025
- Dividend Yield
- CMPX N/A
- ACDC N/A
- EPS Growth
- CMPX N/A
- ACDC N/A
- EPS
- CMPX N/A
- ACDC N/A
- Revenue
- CMPX N/A
- ACDC $2,132,200,000.00
- Revenue This Year
- CMPX N/A
- ACDC N/A
- Revenue Next Year
- CMPX N/A
- ACDC N/A
- P/E Ratio
- CMPX N/A
- ACDC N/A
- Revenue Growth
- CMPX N/A
- ACDC N/A
- 52 Week Low
- CMPX $1.27
- ACDC $3.43
- 52 Week High
- CMPX $4.86
- ACDC $10.70
- Technical
- Relative Strength Index (RSI)
- CMPX 53.07
- ACDC 57.30
- Support Level
- CMPX $3.86
- ACDC $3.70
- Resistance Level
- CMPX $4.86
- ACDC $4.10
- Average True Range (ATR)
- CMPX 0.31
- ACDC 0.25
- MACD
- CMPX -0.05
- ACDC 0.09
- Stochastic Oscillator
- CMPX 38.43
- ACDC 75.52
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.